Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GLPG

Galapagos (GLPG)

Galapagos
Date:
Sort by:
 Showing the most relevant articles for your search:EU:GLPG
DateTimeSourceHeadlineSymbolCompany
06/17/20141:39AMGlobeNewswire Inc.Galapagos cystic fibrosis program progresses towards therapy for largest patient groupEU:GLPGGalapagos
05/12/201412:05PMGlobeNewswire Inc.Galapagos to hold Annual R&D Update on 17 June 2014 in New YorkEU:GLPGGalapagos
04/30/201412:07PMGlobeNewswire Inc.Invitation to the Extraordinary General Shareholders' Meeting to be held on 19 May 2014EU:GLPGGalapagos
04/28/20141:34AMGlobeNewswire Inc.Galapagos announces management changeEU:GLPGGalapagos
04/24/201412:06PMGlobeNewswire Inc.Baker Brothers notify of 4.99% shareholding in GalapagosEU:GLPGGalapagos
04/17/20141:03AMGlobeNewswire Inc.GSK2586184 met primary endpoint in Phase 2a psoriasis studyEU:GLPGGalapagos
04/10/201412:05PMGlobeNewswire Inc.Galapagos raises EU2.4 million through warrant exercisesEU:GLPGGalapagos
04/01/20141:35AMGlobeNewswire Inc.Charles River Laboratories and Galapagos complete transactionEU:GLPGGalapagos
03/28/20143:24PMGlobeNewswire Inc.Invitation to the Annual and Extraordinary General Shareholders' Meetings to be held on 29 April 2014EU:GLPGGalapagos
03/21/20146:46AMGlobeNewswire Inc.Euronext Amsterdam to become Market of Reference for GalapagosEU:GLPGGalapagos
03/18/20142:37AMGlobeNewswire Inc.Galapagos to present favorable pre-clinical data on GLPG1790, a selective ephrin receptor kinase inhibitor, at AACR in San Di...EU:GLPGGalapagos
03/13/20142:53AMGlobeNewswire Inc.Charles River Laboratories to acquire Galapagos' Argenta and BioFocus service operations for up to EU134 millionEU:GLPGGalapagos
03/07/20141:37AMGlobeNewswire Inc.Galapagos reports 2013 financial resultsEU:GLPGGalapagos
03/07/20141:22AMGlobeNewswire Inc.Galapagos receives EU2 million from osteoarthritis alliance with ServierEU:GLPGGalapagos
09/24/20139:01AMDow Jones NewsAbbVie Enters Collaboration With Galapagos to Develop Cystic Fibrosis TreatmentsEU:GLPGGalapagos
04/18/201211:26AMDow Jones News2nd UPDATE: Abbott Labs 1Q Net Rises On Strong Drug, Nutritional SalesEU:GLPGGalapagos
04/18/20129:21AMDow Jones NewsUPDATE:Abbott Labs 1Q Net Rises On Strong Drug,Nutritional SalesEU:GLPGGalapagos
02/29/201210:00AMDow Jones NewsAbbott, Galapagos To Commercialize Autoimmune TreatmentEU:GLPGGalapagos
01/11/20112:26AMDow Jones NewsGalapagos Gets EUR7.4Mln Milestone In Alliance With GSKEU:GLPGGalapagos
01/11/20112:26AMDow Jones NewsGalapagos Gets EUR7.4Mln Milestone In Alliance With GSKEU:GLPGGalapagos
09/08/20102:53AMDow Jones NewsBelgian Galapagos Buys Research Center From GlaxoSmithKlineEU:GLPGGalapagos
02/22/20102:44AMDow Jones NewsGalapagos Identifies New Candidate Drug For ArthritisEU:GLPGGalapagos
12/16/20095:15AMDow Jones NewsLONDON MARKETS: U.K. Stocks Rise On Economic OptimismEU:GLPGGalapagos
12/16/20093:17AMDow Jones NewsGalapagos, GlaxoSmithKline Deepen Arthritis AllianceEU:GLPGGalapagos
12/08/20092:32AMDow Jones NewsGalapagos Gets EUR4 Million Milestone Payment From GlaxoSmithKlineEU:GLPGGalapagos
 Showing the most relevant articles for your search:EU:GLPG